Marta Batus to Antibodies, Monoclonal
This is a "connection" page, showing publications Marta Batus has written about Antibodies, Monoclonal.
Connection Strength
0.747
-
Marta Batus on the New Direct-to-Consumer Advertising for Nivolumab, and Its Impact on Oncology Practice. Oncology (Williston Park). 2016 Jun; 30(6):506, 523.
Score: 0.496
-
Future directions for pediatric and young adult bone sarcoma. Curr Probl Cancer. 2013 Jul-Aug; 37(4):225-35.
Score: 0.101
-
Primary and secondary therapeutic strategies for EGF receptor pathway inhibition in non-small-cell lung cancer. Expert Rev Anticancer Ther. 2010 Oct; 10(10):1589-99.
Score: 0.084
-
Effects of ERBB2 amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancer. Genes Chromosomes Cancer. 2007 Apr; 46(4):397-405.
Score: 0.066